Gordon W. Duff

Q: What Schools Are Affiliated With Gordon W. Duff

Gordon W. Duff is affiliated with the following schools: University of Sheffield, University of Edinburgh

Gordon W. Duff's AcademicInfluence.com Rankings

Gordon W. Duff

Philosophy

#7929

World Rank

#11213

Historical Rank

Logic

#4964

World Rank

#6309

Historical Rank

philosophy Degrees

Gordon W. Duff

Biology

#10684

World Rank

#14036

Historical Rank

Genetics

#1139

World Rank

#1238

Historical Rank

Molecular Biology

#1576

World Rank

#1604

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Gordon W. Duff's Degrees

PhD Molecular Biology University of California, Berkeley
Doctorate Medicine Stanford University

Why Is Gordon W. Duff Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gordon W. Duff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. (1997) (2338)
The interleukin-1 genotype as a severity factor in adult periodontal disease. (1997) (1228)
Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. (1992) (944)
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles (1993) (718)
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat (1993) (561)
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS (1988) (503)
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. (2006) (494)
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. (1998) (490)
Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. (1994) (433)
Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) (1992) (351)
Interleukin 1: the first interleukin. (1990) (343)
Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. (2008) (333)
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene (2000) (322)
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. (2006) (312)
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism (1995) (311)
Evidence for an Accessory Protein Function for Toll-Like Receptor 1 in Anti-Bacterial Responses1 (2000) (310)
A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes (1994) (295)
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. (1994) (293)
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. (1988) (266)
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. (1999) (241)
Interleukin-1 genetic association with periodontitis in clinical practice. (2000) (240)
Human Decidua: A Source of Interleukin-1 (1989) (233)
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. (1995) (227)
Tumour necrosis factor in synovial exudates. (1988) (222)
Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. (1991) (222)
Mechanisms of fever induced by recombinant human interferon. (1984) (221)
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. (1987) (220)
A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha (1994) (217)
Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. (2000) (202)
An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. (1998) (199)
A sequence-based map of the nine genes of the human interleukin-1 cluster. (2002) (195)
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. (2000) (195)
Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. (1994) (191)
Sequence homologies between hsp60 and autoantigens. (1993) (187)
The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. (1982) (181)
Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. (2004) (180)
Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). (1992) (179)
Purification and characterization of a novel soluble receptor for interleukin 1 (1991) (175)
Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. (1995) (168)
IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. (2003) (165)
In situ hybridisation. (1990) (165)
Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. (2000) (162)
Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. (2000) (161)
A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. (1994) (161)
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. (1995) (154)
Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response (1983) (149)
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. (2004) (139)
Patient Stratification for Preventive Care in Dentistry (2013) (138)
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. (2000) (138)
Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. (1995) (132)
Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: a systematic review and meta-analysis. (2012) (129)
Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. (1999) (129)
Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. (1998) (128)
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. (2000) (127)
C-reactive protein levels are influenced by common IL-1 gene variations. (2002) (125)
The pyrogenic and mitogenic actions of interleukin-1 are related (1983) (116)
The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. (2001) (116)
Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). (2014) (112)
No independent association between a tumor necrosis factor‐α promotor region polymorphism and insulin‐dependent diabetes mellitus (1993) (110)
Heat-shock protein 65 as a β cell antigen of insulin-dependent diabetes (1990) (106)
Interleukin-1 receptor antagonist allele (ILIRN*2) associated with nephropathy in diabetes mellitus (1996) (98)
Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus (1994) (96)
TNF2, a polymorphism of the tumour necrosis‐α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype (1996) (96)
Dating the Origin of the CCR 5D 32 AIDS-Resistance Allele by the Coalescence of Haplotypes (2007) (88)
Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. (1999) (87)
In situ hybridization of IL‐6 in rheumatoid arthritis (1992) (87)
Failure to detect paramyxovirus sequences in paget's disease of bone using the polymerase chain reaction (1991) (86)
Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? (1988) (84)
Cytokines and acute phase proteins in rheumatoid arthritis. (1994) (83)
Interleukin-1: a key inflammatory mediator in psoriasis? (2006) (82)
Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty (2003) (80)
Association between interleukin‐1 receptor antagonist (IL‐1ra) gene polymorphism and early and late‐onset psoriasis (1997) (78)
IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1β and C-reactive protein (2008) (78)
Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. (1999) (77)
Soluble interleukin 2 receptor in atopic eczema. (1989) (77)
Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease (2003) (77)
Age-related loss of CpG methylation in the tumour necrosis factor promoter. (2011) (77)
The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. (1982) (76)
A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1beta gene. (1997) (75)
Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. (1999) (75)
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians (2001) (72)
In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. (1992) (72)
Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. (2002) (71)
A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. (1995) (69)
Evidence that brain prostaglandin synthesis is not essential in fever. (1976) (65)
Interleukin‐1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise (2004) (64)
Genetic polymorphism of human interleukin‐1α (1993) (62)
A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis (2007) (62)
Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region (2000) (62)
Human Biochemistry (1983) (62)
Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis (2005) (61)
Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. (1985) (60)
IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. (2013) (59)
A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells. (1990) (58)
A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo (2001) (58)
Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. (1991) (55)
Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus (2001) (55)
Candidate genes as potential links between periodontal and cardiovascular diseases. (2001) (53)
An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. (1995) (53)
A soluble form of the interleukin‐1 receptor produced by a human B cell line (1990) (51)
Release of platelet-derived growth factor activity from pig venous arterial grafts. (1994) (50)
Soluble CD8 in patients with rheumatic diseases (1990) (48)
The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. (1983) (47)
Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment (1996) (47)
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. (2002) (47)
An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation. (1996) (44)
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis (2004) (44)
Genetic variations and inflammation: a practical nutrigenomics opportunity. (2004) (41)
Identification of an interleukin‐1 beta binding protein in human plasma (1990) (41)
Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. (1995) (41)
Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration (1993) (40)
Quo vadis: what is the future of periodontics? How will we get there? (2017) (39)
Autoregulation of interleukin 1 production (1989) (38)
Personalized Medicine (2012) (36)
Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis (2005) (35)
Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation. (1982) (34)
Interleukin 1 Activity Produced by Human Rheumatoid and Normal Dendritic Cells (1986) (33)
Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. (1989) (33)
Plasma levels of interleukin-1-alpha in rheumatoid arthritis. (1991) (32)
Effects of a Tumour Necrosis Factor (TNFα) Promoter Base Transition on Trancriptional Activity (1994) (32)
Immune diseases: Many roles for interleukin-1 (1985) (31)
Absence of lentiviral and human T cell leukemia viral sequences in patients with rheumatoid arthritis. (1994) (31)
Rheumatoid Arthritis Synovial Dendritic Cells Produce Interleukin-1 (1985) (30)
Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. (1990) (29)
Tumournecrosis factor insynovial exudates (1988) (27)
Interaction between HLA-DR and HLA-DP, and between HLA and interleukin 1 alpha in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease. (1995) (26)
Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. (1996) (25)
Evidence for genetic variation as a factor in maintaining health. (2006) (25)
The 3'-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability. (2011) (25)
Modulation of interleukin 1 beta gene expression using antisense phosphorothioate oligonucleotides. (1990) (25)
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5 (2008) (25)
Association analysis of IL1A and IL1B variants in alopecia areata (2001) (23)
Genetic traits in common diseases (1995) (23)
Cytokine Gene Polymorphisms in Heavy Drinkers With and Without Decompensated Liver Disease: A Case-Control Study (2008) (22)
An AP-1 site is involved in the NGF induction of IL-1α in PC12 cells (1996) (22)
Human interleukin-1α gene expression is regulated by Sp1 and a transcriptional repressor (2005) (22)
The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production. (1984) (21)
Interleukin 8 in rheumatoid and osteoarthritis. (1992) (21)
Cytokines and anti-cytokines. (1993) (20)
Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement. (1990) (20)
Endotoxins and Their Detection with the Limulus Amebocyte Lysate Test (1983) (20)
Kinetics of IL1 beta mRNA and protein accumulation in human mononuclear cells. (1991) (17)
THE EFFECTS OF GAMOLENIC ACID ON ADULT ATOPIC ECZEMA AND PREMENSTRUAL EXACERBATION OF ECZEMA (1994) (16)
Soluble interleukin-2 receptor and disease activity in Crohn's disease. (1992) (16)
Thermoregulation in rabbits during fever. (1976) (16)
Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases (2004) (16)
Personalized Medicine: Will Dentistry Ride the Wave or Watch from the Beach? PERSPECTIVE (2012) (16)
Arthritis and interleukins. (1988) (14)
Is fever beneficial to the host: a clinical perspective. (1986) (14)
Genetic polymorphism of human interleukin-1 alpha. (1993) (14)
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related. (1988) (13)
Polymorphic tandem repeat region in interleukin-1α intron 6 (1993) (13)
Re: A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis. Greenstein G, Hart TC (2002;73:231-247). (2002) (13)
Cytokines as Genetic Modifying Factors in Immune and Inflammatory Diseases (1996) (13)
Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatibility complex haplotype for psoriasis in a Caucasian population. (2005) (12)
British Association for the Study of the Liver (1991) (11)
Psoriasis and Interleukin-1 (1993) (10)
Human interleukin-1 alpha gene expression is regulated by Sp1 and a transcriptional repressor. (2005) (10)
Influence of genetics on disease susceptibility and progression. (2007) (9)
Counterpoint: Risk factors, including genetic information, add value in stratifying patients for optimal preventive dental care. (2015) (9)
Interleukin-1 in inflammatory joint disease (1989) (9)
Polymorphic tandem repeat region in interleukin-1 alpha intron 6. (1993) (9)
The bioassay of human endogenous pyrogen. (1973) (9)
Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section. (1998) (8)
Is there no role for heat-shock protein in diabetes? (1991) (7)
Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM (1994) (7)
Mycosis fungoides with squamous cell carcinoma (1979) (7)
7B6, a ubiquitous mRNA: with significant homology to L41 human ribosomal protein RNA. (1993) (7)
Soluble mediators of immunity: interleukins (1988) (7)
Interleukin-1 receptor antagonist and genetic susceptibility to inflammation. (1994) (6)
Relevance of experimental observations to pyrexia in clinical situations in: pyrogens and fever. (2008) (6)
Removal of endotoxin by a polymyxin B affinity column (1982) (6)
Allele 2 of the interleukin-1 receptor antagonist gene polymorphism is associated with reduced expression of interleukin-1 receptor antagonist in ulcerative colitis (1998) (6)
An AP-1 site is involved in the NGF induction of IL-1 alpha in PC12 cells. (1996) (6)
Interleukin I beta in synovial fluid is related to local disease activity in rheumatoid arthritis (4)
Comparative aspects of host-parasite and host-tumor relationships. (1992) (4)
Interleukin 1 in rheumatoid arthritis (1989) (4)
Association of the interleukin one receptor antagonist gene polymorphism with lichen sclerosus (1994) (4)
Independent Effects of Interleukin‐6 (IL‐6) and Interleukin‐1 (IL‐1) on Accumulation of Specific mRNA for Fibrinogen and for Serum Amyloid A in Human Hepatoma (HepG2) Cells a (1989) (4)
Intron 1 regulation of interleukin 1 beta (IL-1β) gene transcription: an alternative promoter? (1994) (3)
Studies on the production of endogenous pyrogen by rabbit monocytes: the role of calcium and cyclic nucleotides. (1985) (3)
Promoter region polymorphism in the human TNF‐α gene is not associated with lichen sclerosus (1996) (3)
Inhibition of il1 driven t cell mitogenesis by synovial exudate fluids from patients with ra and oa (1986) (3)
Interleukin 1 as an inflammatory mediator (1992) (3)
Interleukin-1 and Fever (1985) (3)
Epidermal barrier dysfunctionin atopic dermatitis (2008) (3)
Interleukin 1 and Tumour Necrosis Factor in the Pathogenesis of Septic Arthritis (1989) (3)
Drugs Affecting the Immune Response (2020) (2)
British Society for Investigative Dermatology Annual Meeting, Manchester, September 1988 (1989) (2)
IL-1 gene polymorphism and smoking, risk factors for peri-implant bone loss? (2002) (2)
Further evidence of an association between the allele 2 of the interleukin-1 receptor antagonist (IL-1RA) gene (IL-1RN) polymorphism and ulcerative colitis (UC)* (1998) (2)
Gene–environment interactions in atopic dermatitis (2008) (2)
Characterization of a second transcription initiation element (STIE) in the human interleukin-1 beta (IL-1beta) gene. (1998) (2)
Interleukin-1 Beta Gene Polymorphism is Associated with Autoimmune Hepatitis (AIH) (1996) (2)
A tumour necrosis factor (x polymorphism is not associated with rheumatoid arthritis (2004) (2)
An Allelic Polymorphism within the Human Tumor Necrosis Factor ol Promoter Region Is Strongly Associated with HLA A1, B8, and DR3 Alleles By A. G. Wilson* N. de Vries,~ F. Pociot,$ F. S. di Giovine,* (1993) (1)
Tumor necrosis factor. (1995) (1)
Relevance of tumour necrosis factor alpha gene polymorphism in rheumatic disease. (1999) (1)
Cytokine gene activation across the advancing edge of psoriatic plaques (1993) (1)
National scientific medical meeting 1995 abstracts (1995) (1)
Cytokine gene polymorphisms in inflammatory dermatoses (1993) (1)
Can augmentation index be used as an accurate tool in the diagnosis of peripheral obstructive arterial disease? (2012) (1)
Current and Future Trends: Skin Diseases and Treatment (2012) (1)
390 PROGRESSION OR INITIATION OF RADIOGRAPHIC KNEE OSTEOARTHRITIS AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT (2010) (1)
Efficacy and safety of cytokines for human therapy. Report of an EC Study Group. (1993) (1)
Biology and clinical relevance of IL-1 (1988) (0)
Method for determining susceptibility to developing sepsis and therapeutic compounds for treatment and sepsis. (1999) (0)
Interleukin-1 (IL-1) gene polymorphisms: Risk of coronary arterial disease (1998) (0)
Overview of the Interleukin-1 Genetic Test as a Risk Factor for Guiding Effective and Efficient Prevention and Treatment of Periodontitis (2014) (0)
Laboratory and radiologic investigations in the diagnosis and evaluation of rheumatoid arthritis. (1990) (0)
Death in meningococcal disease and polymorphisms of pro-inflammatory cytokine genes (1999) (0)
Recombinant DNA Proteins and Prospects for Treatment of Inflammatory Diseases (1988) (0)
PATHOGENESIS OF INFLAMMATION (1987) (0)
An Allelic Po lymorphism within the H u m a n Tumor Necrosis Factor ol Promoter Region Is Strongly Associated with H LA A 1 , B 8 , and D R 3 Alleles (2003) (0)
Irish Association For Rheumatology And Rehabilitation Annual General Meeting, Friday, Nov. 4Th At Beaumont Hospital (1989) (0)
Association of interleukin-1α and interleukin-1β gene alleles with ulcerative colitis: Evidence for genetic susceptibility (2001) (0)
Method of diagnosis and therapy for diseases associated with an il-1 inflammatory hoplotipo. (2005) (0)
A possible role for the interleukin-1 genes in early onset psoriatic arthritis (1999) (0)
RE: INNOVATIVE NEW BENEFIT FOR CYTOKINE+ SUBSCRIBERS (2001) (0)
Diagnosis and therapy for chronic obstructive disease of the respiratory tract. (1998) (0)
Irish association for rheumatology & rehabilitation (1990) (0)
Raised serum levels of soluble interleukin‐2 receptor (sIL2R) in atopic eczema (1988) (0)
Promoter Region Polymorphism in the TNF Gene and Risk of Osteolysis after Total Hip Arthroplasty (2002) (0)
Atumournecrosis factor (xpolymorphism isnot associated withrheumatoid arthritis (1995) (0)
Diagnosis and therapy for osteoporosis. (2000) (0)
Translating immunobiology into clinical therapeutics (2007) (0)
Pharmacogenomics for Oral Disease (2015) (0)
IsFever Beneficial totheHost: AClinical Perspective (1986) (0)
Corrigendum: Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis (Human Molecular Genetics (2000) 8 (1135-1140)) (2000) (0)
Sources, Inducers and Clinical Effects of Interleukin-1 (1985) (0)
Cytokine, a successful new journal (1991) (0)
Responsesfor Toll-Like Receptor 1 in Anti-Bacterial Evidence for an Accessory Protein Function (2000) (0)
Toll-like receptor multimerisation in lipopolysaccharide signalling (2000) (0)
Observations on the transmitter function of noradrenaline in the central control of body temperature in the rabbit. (1972) (0)
Studies ontheProduction ofEndogenous Pyrogen byRabbit Monocytes: TheRoleofCalcium andCyclic Nucleotides (1985) (0)
1028-166 Association of coronary heart disease with interleukin-1 gene variants in the atherosclerosis risk in communities study (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gordon W. Duff?

Gordon W. Duff is affiliated with the following schools:

Gordon W. Duff's Academic­Influence.com Rankings

Gordon W. Duff's Degrees

Why Is Gordon W. Duff Influential?

Gordon W. Duff's Published Works

Published Works

What Schools Are Affiliated With Gordon W. Duff?

Gordon W. Duff's AcademicInfluence.com Rankings